Pfizer (PFE): A Healthcare Giant Offering Steady Dividend Income

Pfizer Inc. (NYSE:PFE) is included among the 10 Highest Dividend-Paying Stocks to Buy in the S&P 500.

Pfizer Inc. (NYSE:PFE) is a US pharmaceutical and biotech giant that provides various allied products and services to its customers. In recent years, the company has made several moves to fill its drug pipeline, most notably its $43 billion acquisition of Seagen, a cancer-focused company. The pharmaceutical behemoth is, meanwhile, mirroring these moves to broaden its GLP-1 line. The company recently revealed that it will purchase Metsera, a firm that is designing treatments for managing weight, for $4.9 billion in cash.

Although it’s too early to say whether any of these drugs will be successful in clinical trials, the products of Metsera are focused on addressing a popular area of the GLP-1 market. Overall, Pfizer Inc. (NYSE:PFE)’s core business fundamentals mean this stock may be attractive for the long run.

Pfizer Inc. (NYSE:PFE) is one of the best dividend stocks as it has raised its payouts for 15 straight years. The company offers a quarterly dividend of $0.43 per share, and the dividend yield is 7.24%, as of Sep 27.

While we acknowledge the potential of PFE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: Dividend Capture Strategy: 15 High Yield Stocks to Buy in October and 10 Cash-Rich Dividend Stocks to Buy Right Now.

Disclosure: None.